Skip to content

Viking Therapeutics

US · VKTX #2352 by market cap Listed 2015
24.77 -1.07 -4.14%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:56

About Viking Therapeutics

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Founded
2012
CEO
Dr. Brian Lian, PhD
Employees
53
Headquarters
San Diego, California, United States of America
Fiscal year end
12-31
Website
vikingtherapeutics.com

Company profile

Exchange
US
Symbol
VKTX
Market-cap rank
#2352
Listing date
2015-04-29
Market cap
3.16B
Float cap
3.09B
Shares out
127.52M
Float shares
124.60M

Sectors & themes

Biotechnology Weight Loss Drugs Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:56:05 · For reference only, not investment advice and not tailored to your situation.

Viking Therapeutics discussion 0 comments

Add a comment